Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Investment trusts have a number of tricks up their sleeves that mean they can boost their dividend payouts. This is what to ...

Since abrdn's acquisition in 2023, HQL has delivered a total return of 25.5%, though its price appreciation has been modest.

The manuscript addresses the 3D chromatin architecture in monocytes from patients with alcohol-associated hepatitis and its relationship to enhanced transcription of innate immune genes. While the ...

In coming years, the pace of technological innovation and deployment will only quicken. The new administration will need a ...

It’s widely recognized that health care is a growing expense for many Americans. However, what health care companies do with their profits — some made through government programs such as Medicare — ...

Biotechnology can help to make this process more affordable and sustainable. As an example, Novonesis, previously known as Novozymes, is working on a technique to improve carbon capture, called ...

By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in antibiotic resistance.

Using a series of more than 1,000 X-ray snapshots of the shapeshifting of enzymes in action, researchers at Stanford ...

Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...

Discover why income-focused investors are eyeing HQH with its high dividend yield and discounted NAV, despite sector-specific ...